Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interactions of hypotensive agents].

H Adamska-Dyniewska1

  • 1Zakładu Farmakologii Klinicznej IMW WAM w Lodzi.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|December 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Effect of one-year treatment with low simvastatin doses on lipids and Lp(a) in patients with significant hypercholesterolemia].

Polskie Archiwum Medycyny Wewnetrznej·1998
Same author

Bisoprolol in the treatment of hypertension in the elderly.

Journal of human hypertension·1998
Same author

Efficacy and safety of one-year treatment with slow-release nicotinic acid. Monitoring of drug concentration in serum.

International journal of clinical pharmacology and therapeutics·1998
Same author

[Prolonged treatment with slow release nicotinic acid in patients with type II hyperlipidemia].

Polskie Archiwum Medycyny Wewnetrznej·1998
Same author

[Lovastatin in the treatment of hypercholesterolemia].

Polskie Archiwum Medycyny Wewnetrznej·1994
Same author

[Monitoring treatment with amikacin for urinary tract infections].

Polski tygodnik lekarski (Warsaw, Poland : 1960)·1993

Drug interactions, especially pharmacokinetic ones involving cytochrome P450 enzymes, can lead to adverse outcomes. Understanding metabolic mechanisms of drug interactions is key for safe use of hypotensive agents.

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Clinical Therapeutics

Context:

  • Drug interactions are a significant cause of adverse clinical events.
  • Understanding these interactions is crucial for patient safety.
  • Recent advances in understanding drug metabolism have improved the study of drug interactions.

Purpose:

  • To review the metabolic mechanisms of clinically significant drug interactions.
  • To focus on interactions involving major classes of hypotensive agents.
  • To elucidate the scientific principles underlying drug interactions.

Summary:

  • Drug interactions are categorized as pharmacokinetic, pharmacodynamic, or both.
  • Pharmacokinetic interactions involve alterations in a drug's absorption, distribution, metabolism, or excretion.

Related Experiment Videos

  • Cytochrome P450 enzymes play a critical role in drug metabolism and interactions.

    • Impact:

    • Provides a framework for understanding complex drug interactions.
    • Highlights the importance of metabolic mechanisms in drug therapy.
    • Aims to improve clinical recognition and management of drug interactions.